CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $192,000 | -37.7% | 45,344 | -26.6% | 0.00% | -100.0% |
| Q1 2021 | $308,000 | -60.6% | 61,772 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $781,000 | +28.7% | 61,772 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $607,000 | -34.3% | 61,772 | -33.5% | 0.00% | 0.0% |
| Q2 2020 | $924,000 | -29.5% | 92,910 | -37.3% | 0.00% | -33.3% |
| Q1 2020 | $1,310,000 | -4.1% | 148,166 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,366,000 | +56.7% | 148,166 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $872,000 | -65.6% | 148,166 | -29.8% | 0.00% | -60.0% |
| Q2 2019 | $2,532,000 | +651.3% | 210,966 | +656.2% | 0.01% | +400.0% |
| Q1 2019 | $337,000 | +31.1% | 27,900 | +61.3% | 0.00% | 0.0% |
| Q3 2018 | $257,000 | -11.7% | 17,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $291,000 | -51.5% | 17,300 | -34.0% | 0.00% | -50.0% |
| Q1 2018 | $600,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |